Evidence map›Paper›PMID 34019813›Full record

ArticleStem cell reports2021

Megakaryocyte progenitor cell function is enhanced upon aging despite the functional decline of aged hematopoietic stem cells.

Donna M Poscablo, Atesh K Worthington, Stephanie Smith-Berdan, E Camilla Forsberg

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 43 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Direct megakaryopoiesis.Current opinion in hematology · 2025
    Review
  14. Review
  15. Article
  16. Review
  17. Frontiers in immunology · 2025
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Donna M PoscabloInstitute for the Biology of Stem Cells, University of California-Santa Cruz, Santa Cruz, CA, USA; Program in Biomedical Sciences and Engineering, Department of Molecular, Cell, and Developmental Biology, University of California-Santa Cruz, Santa Cruz, CA 95064, USA.
Atesh K WorthingtonInstitute for the Biology of Stem Cells, University of California-Santa Cruz, Santa Cruz, CA, USA; Program in Biomedical Sciences and Engineering, Department of Molecular, Cell, and Developmental Biology, University of California-Santa Cruz, Santa Cruz, CA 95064, USA.
Stephanie Smith-BerdanInstitute for the Biology of Stem Cells, University of California-Santa Cruz, Santa Cruz, CA, USA.
E Camilla ForsbergInstitute for the Biology of Stem Cells, University of California-Santa Cruz, Santa Cruz, CA, USA; Biomolecular Engineering, University of California-Santa Cruz, Santa Cruz, CA, USA. Electronic address: cforsber@ucsc.edu.
University of California, Santa Cruz · US

Funding

UNIVERSITY OF CALIFORNIA, SANTA CRUZ IMSD PROGRAMR25GM058903 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI JURICA, MELISSA S · 1999 to 2019
$12.2M
Defining the cause and consequence of aging-specific platelet specification from hematopoietic stem cellsR01AG062879 · NIA · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI CAMILLA FORSBERG · 2019 to 2026
$4.9M
Defining regulators of hematopoietic stem cell self-renewal and lineage potentialF31HL151199 · NHLBI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI WORTHINGTON, ATESH K · 2020 to 2022
$115k
Howard Hughes Medical InstituteNHLBI NIH HHS F31 HL151199NIA NIH HHS R01 AG062879NIGMS NIH HHS R25 GM058903
6 · The paper itself

Abstract

Age-related morbidity is associated with a decline in hematopoietic stem cell (HSC) function, but the mechanisms of HSC aging remain unclear. We performed heterochronic HSC transplants followed by quantitative analysis of cell reconstitution. Although young HSCs outperformed old HSCs in young recipients, young HSCs unexpectedly failed to outcompete the old HSCs of aged recipients. Interestingly, despite substantial enrichment of megakaryocyte progenitors (MkPs) in old mice in situ and reported platelet (Plt) priming with age, transplanted old HSCs were deficient in reconstitution of all lineages, including MkPs and Plts. We therefore performed functional analysis of young and old MkPs. Surprisingly, old MkPs displayed unmistakably greater regenerative capacity compared with young MkPs. Transcriptome analysis revealed putative molecular regulators of old MkP expansion. Collectively, these data demonstrated that aging affects HSCs and megakaryopoiesis in fundamentally different ways: whereas old HSCs functionally decline, MkPs gain expansion capacity upon aging.

Indexed as

ThrombopoiesisTranscriptomeAgingAnimalsCell LineageFemaleHematopoietic Stem CellsHematopoietic Stem Cell TransplantationMaleMegakaryocyte Progenitor CellsMiceMice, Inbred C57BLage-related hematopoiesiscell-extrinsiccell-intrinsichematopoietic stem cellheterochronic HSC transplantsmegakaryocyte progenitorsplateletsquantitative reconstitutionregenerative capacitytranscriptome

Identifiers

PMID34019813
PMCPMC8190594
OpenAlexW3161048064

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.